SEC Form 4
Chemed Corporation (CHE) insider trading
In the 12 months to Oct 24, 2026, 5 CHE insiders reported open-market sales of $8.8M across 13 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $8.8M
- 13 filings · 5 insiders
- Open-market purchases
- $0
- 0 filings
Who traded CHE, and when
- Sale
CHE daily close from Oct 24, 2025 to Oct 23, 2026, between $368.59 and $552.72, last $512.98. 13 sale and 0 purchase filings by 5 insiders, marked at their filing dates. Kevin J. Mcnamara, president and CEO: sold $7.3M across 8 filings, first filed Nov 25, 2025, last Sep 30, 2026. Andrea R. Lindell, Director: sold $602.6K across 1 filing, first filed Jun 10, 2026, last Jun 10, 2026. Spencer S. Lee, executive vice president: sold $541.0K across 1 filing, first filed Aug 24, 2026, last Aug 24, 2026. George J. Walsh III, Director: sold $218.9K across 1 filing, first filed May 29, 2026, last May 29, 2026. Patrick P. Grace, Director: sold $126.6K across 2 filings, first filed May 8, 2026, last Aug 3, 2026.
Largest mark · tap a row for others
Kevin J. Mcnamara · president and CEO
Sale $1,082,320
2,000 shares at $541.16 avg
Filed Aug 24, 2026 · traded Aug 21
Close on filing date $541.34
Kevin J. Mcnamara · president and CEO
president and CEO
$7.3M soldAndrea R. Lindell · Director
Director
$602.6K soldSpencer S. Lee · executive vice president
executive vice president
$541.0K soldGeorge J. Walsh III · Director
Director
$218.9K soldPatrick P. Grace · Director
Director
$126.6K soldHas the Chemed Corporation's CEO sold stock?
Yes. Kevin J. Mcnamara (CEO) sold 15,500 shares ($7.3M) between Nov 2025 and Sep 2026. Joel L. Wherley (CEO) made no open-market sales filed as CEO in the last 12 months.
Open-market trades
13 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Kevin J. Mcnamara | president and CEO | $7.3M | — | 8 | — | |
| Andrea R. Lindell | Director | $602.6K | — | 1 | — | |
| Spencer S. Lee | executive vice president | $541.0K | — | 1 | — | |
| George J. Walsh III | Director | $218.9K | — | 1 | — | |
| Patrick P. Grace | Director | $126.6K | — | 2 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Kevin J. Mcnamara president and CEO | Sale | 2,000 | $513.45 | $1.0M | 66,418 | |
traded | Kevin J. Mcnamara president and CEO | Sale | 2,000 | $501.40 | $1.0M | 68,418 | |
traded | Kevin J. Mcnamara president and CEO | Sale | 2,000 | $541.16 | $1.1M | 70,418 | |
traded | Spencer S. Lee executive vice president | Sale | 1,000 | $541.04 | $541.0K | 13,912 | |
traded | Kevin J. Mcnamara president and CEO | Sale | 2,000 | $539.51 | $1.1M | 70,418 | |
traded | Patrick P. Grace Director | Sale | 190 | $532.00 | $101.1K | 3,533 | |
traded | Andrea R. Lindell Director | Sale | 1,347 | $447.33 | $602.6K | 4,578 | |
traded | George J. Walsh III Director | Sale | 500 | $437.83 | $218.9K | 3,209 | |
traded | Patrick P. Grace Director | Sale | 60 | $425.78 | $25.5K | 3,337 | |
traded | Kevin J. Mcnamara president and CEO | Sale | 2,000 | $421.13 | $842.3K | 90,219 | |
traded | Kevin J. Mcnamara president and CEO | Sale | 1,500 | $369.37 | $554.1K | 92,219 | |
traded | Kevin J. Mcnamara president and CEO | Sale | 2,000 | $403.18 | $806.4K | 93,719 | |
traded | Kevin J. Mcnamara president and CEO | Sale | 2,000 | $437.55 | $875.1K | 94,197 |
GET /stocks/filings/vX/form-4?tickers=CHE&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"CHE"
],
"issuer_cik": "0000019584",
"owner_cik": "0001207137",
"accession_number": "0001193125-26-408869",
"form_type": "4",
"filing_date": "2026-09-30",
"period_of_report": "2026-09-28",
"issuer_name": "CHEMED CORP",
"issuer_trading_symbol": "CHE",
"owner_name": "MCNAMARA KEVIN J",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "president and CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Capital Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-28",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 2000,
"transaction_price_per_share": 513.45,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 66418,
"transaction_value": 1026900.0000000001,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.93 to $515.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4."
}
]
},
{
"tickers": [
"CHE"
],
"issuer_cik": "0000019584",
"owner_cik": "0001207137",
"accession_number": "0001193125-26-396365",
"form_type": "4",
"filing_date": "2026-09-21",
"period_of_report": "2026-09-18",
"issuer_name": "CHEMED CORP",
"issuer_trading_symbol": "CHE",
"owner_name": "MCNAMARA KEVIN J",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "president and CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Capital Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-18",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 2000,
"transaction_price_per_share": 501.4,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 68418,
"transaction_value": 1002800,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $501.00 to $502.05. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 37 records
- Option exercises17 records
- Tax withholding11 records
- Grants and awards7 records
- Gifts2 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for CHE every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.